Shandong Buchang Pharmaceuticals Co., Ltd.

SSE:603858.SS

16.84 (CNY) • At close June 12, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20242023202220212020201920182017201620152014201320122011
Assets:
Current Assets:
Cash & Cash Equivalents 818.813694.1312,148.691,217.7021,469.6561,829.3921,693.0682,165.1083,806.6231,851.3392,081.1711,218.9671,485.9071,492.917
Short Term Investments 403.75354.092726.45498.173386.45386.45-27.296-30.866-35.677-34.1740000
Cash and Short Term Investments 1,222.5621,048.2232,875.141,715.8751,856.1062,215.8421,693.0682,165.1083,806.6231,851.3392,081.1711,218.9671,485.9071,492.917
Net Receivables 1,372.4912,039.0531,905.2142,171.4712,638.6831,874.892,606.2582,821.9712,258.6982,045.0132,628.641,289.21,117.6290
Inventory 4,624.3854,930.363,789.0323,834.012,766.8211,925.4841,386.7731,456.8081,188.366984.05842.857843.515467.181453.008
Other Current Assets 317.76255.173422.109630.934724.4241,005.579904.3391,000.3621,165.1421,116.28275.5571,161.5521,228.6261,472.765
Total Current Assets 7,537.1998,280.968,991.4958,352.2897,986.0347,021.7956,203.9877,444.2498,418.835,996.6825,828.2264,513.2344,012.4433,418.69
Non-Current Assets:
Property, Plant & Equipment, Net 5,663.6036,091.9066,300.7345,918.8745,342.6554,725.3113,206.2972,526.2161,808.1531,551.0231,194.112998.063728.452491.245
Goodwill 620.0431,473.0782,062.8785,132.8475,122.0145,067.7215,010.6265,009.8275,009.8275,009.82712.2714.2584.2584.258
Intangible Assets 2,485.3072,326.0462,187.5972,136.4432,106.3681,981.9772,035.922,023.1481,918.1171,922.669680.907569.026346.963244.551
Goodwill and Intangible Assets 3,105.353,799.1244,250.4757,269.297,228.3827,049.6987,046.5467,032.9756,927.9446,932.496693.179573.285351.221248.81
Long Term Investments 1,121.1951,727.926722.23935.2091,051.0131,038.3151,743.7311,255.0841,006.158944.2671,285.353800.627536.150
Tax Assets 389.322368.191221.376220.677170.567210.713154.281138.11179.459107.25467.15122.5216.2344.534
Other Non-Current Assets 1,511.841624.1911,465.5711,289.3021,107.6131,139.4011,670.16800.066434.41123235.50631.79133.655278.435
Total Non-Current Assets 11,791.31112,611.33812,960.38715,633.35314,900.22914,163.43913,821.01411,752.45310,256.1259,767.043,275.3012,426.2861,655.7121,023.024
Total Assets 19,328.50920,892.29821,951.88223,985.64222,886.26421,185.23420,025.00119,196.70318,674.95515,763.7239,103.5276,939.525,668.1554,441.713
Liabilities & Equity:
Current Liabilities:
Account Payables 2,845.6212,496.5242,398.2752,494.5621,938.1541,149.625624.945747.147592.513435.699296.156287.78240.718136.824
Short Term Debt 486.458240.117638.7641,617.4782,561.4961,9051,442.8211,80067011,633.1870210308.7
Tax Payables 141.16883.287286.252349.647407.199264.241428.165469.145283.131407.885334.847183.128105.824129.95
Deferred Revenue 00376.5213,019.3583,201.4742,886.937428.1652,704.0084,816.4365,644.6242,486.081,323.5811,109.5071,019.716
Other Current Liabilities 3,628.9544,036.1183,261.4682,458.1752,570.914-79.2631,990.61-156.1274,775.281-216.658-182.599-38.8441,089.251,060.749
Total Current Liabilities 7,102.2026,856.0466,961.2817,162.2597,813.4646,126.544,922.175,564.1725,656.9246,972.5514,567.5842,625.6441,645.7931,636.224
Non-Current Liabilities:
Long Term Debt 1,988.3732,109.372,153.4811,921.521851.168813.4808001,26115000
Deferred Revenue Non-Current 283.5920330.554345.626340.287335.14294.072250.977145.56692.8250.42425.93100
Deferred Tax Liabilities Non-Current 71.23990.5287.514106.22297.361122.101141.819162.856157.665176.92121.195000
Other Non-Current Liabilities 75.019148.0661440-53.7020000004.0090.2643.902
Total Non-Current Liabilities 2,418.2232,347.9562,715.5492,373.371,261.9651,270.6411,243.891413.834303.2311,530.74186.61929.940.2643.902
Total Liabilities 9,520.4259,516.2889,676.839,535.6299,075.4297,397.1816,166.0615,978.0065,960.1568,503.2924,654.2032,655.5841,646.0571,640.126
Equity:
Preferred Stock 00000000000000
Common Stock 1,106.0431,106.0431,106.0431,141.5811,141.5811,141.581886.34681.8681.86126126126128.686
Retained Earnings 6,747.5177,436.938,179.75810,234.8119,551.1559,494.2918,965.28,276.7727,748.6956,004.782,468.0162,190.4922,039.1482,615.894
Accumulated Other Comprehensive Income/Loss 011.836582.925590.089571.294551.838440.517341.106331.513535.4130.688000
Other Total Stockholders Equity 2,362.9063,062.1853,076.8282,458.3652,450.6132,450.6133,374.7223,842.583,844.008535.411,014.2681,296.3531,157.6554.343
Total Shareholders Equity 10,216.46511,616.99412,362.62814,424.84613,714.64313,638.32213,734.52813,142.25812,606.0167,152.1934,400.9714,098.8443,808.8032,628.922
Total Equity 9,808.08411,376.00912,275.05214,450.01313,810.83513,788.05313,858.9413,218.69712,714.7997,260.434,449.3244,283.9364,022.0982,801.587
Total Liabilities & Shareholders Equity 19,328.50920,892.29821,951.88223,985.64222,886.26421,185.23420,025.00119,196.70318,674.95515,763.7239,103.5276,939.525,668.1554,441.713